At ENTA, we’re constantly monitoring and adjusting our protocols to make sure we are safely and effectively providing the care you need. For more information on how ENTA is taking extra precautions to provide the safest environment possible during the COVID-19 pandemic, please click here.
03/01/2012 in press release
Contact: Jason Campbell
Manager, Marketing and Special Events
ENT and Allergy Associates®, LLP Receives Accreditation by the ICACTL
Computed Tomography (CT) is a highly regarded diagnostic imaging tool due to its ability to detect minute differences in tissue as well as its multiplanar reformatted imaging capabilities. An estimated 62 million CT scans are performed annually in the United States to diagnose conditions of the neck, chest, abdomen, pelvis, extremities, cardiac system and sinus and temporal bones.
Early detection of life threatening conditions and other diseases is possible through the use of CT procedures performed within hospitals, outpatient centers and physicians' offices. While these tests are very helpful, there are many facets that contribute to an accurate diagnosis based on CT testing. The skill of the CT technologist performing the examination, the type of equipment used, the background and knowledge of the interpreting physician and quality assurance measures are each critical to quality patient testing.
ENT and Allergy Associates, LLP in White Plains and West Nyack, NY has been granted a three-year term of accreditation in the areas of Sinus and Temporal Bone CT by the Intersocietal Commission for the Accreditation of Computed Tomography Laboratories (ICACTL). Accreditation by the ICACTL means that ENT and Allergy Associates, LLP has undergone a thorough review of its operational and technical components by a panel of experts.
The ICACTL grants accreditation only to those facilities that are found to be providing quality patient care, in compliance with national standards through a comprehensive application process including detailed case study review.
ICACTL accreditation is a "seal of approval" that patients can rely on as an indication that the facility has been carefully critiqued on all aspects of its operations considered relevant by medical experts in the field of CT. When scheduled for a CT procedure, patients are encouraged to inquire as to the accreditation status of the facility where their examination will be performed and can learn more by visiting http://www.intersocietal.org/ct/.
Commented Wayne Eisman, President of ENTA, “Having this advanced x-ray technology in our office is great because it allows us to perform a scan as part of a patient’s examination, instead of sending the patient off-site to a hospital or imaging center on a full-body CT scanner. This on-site imaging tool Mini Cat CT allows us to diagnose the problem and begin the patients treatment plan right away, giving them faster relief from their symptoms.”
Facts about CT Scanning:
ICACTL accreditation is widely respected within the medical community, as illustrated by the support of the national medical societies related to CT, which include physicians, technologists and physicists. In addition, several insurance companies require their providers of CT services to be accredited, However, patients should remain vigilant in making sure that their CT procedures are performed within accredited laboratories, because for many facilities it remains a voluntary process.
Each of ENT and Allergy Associates’ 36 clinical locations provides access to a full complement of services, including General Adult and Pediatric ENT, Voice and Swallowing, Facial Plastics and Reconstructive Surgery, Disorders of the Inner Ear and Dizziness, Asthma, Clinical Immunology, Diagnostic Audiology, Hearing Aid dispensing, Sleep and CT services. Visit www.entandallergy.com for more information. The practice has a clinical alliance with The Mount Sinai Hospital for the treatment of diseases of the head and neck and a partnership with the American Cancer Society to educate and treat patients with smoking disorders and cancer. The Practice has also expanded its clinical capabilities to include advanced Immunodeficiency trials.